Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

R Lorenzetti; A Zullo; L Ridola; Ap Diamanti; B Laganà; L Gatta; A Migliore; Alessandro Armuzzi; C Hassan; V. Bruzzese

doi:10.3109/07853890.2014.941919

Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

R Lorenzetti^*, A Zullo, L Ridola, Ap Diamanti, B Laganà, L Gatta, A Migliore, Alessandro Armuzzi, C Hassan, V. Bruzzese

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

57 Citazioni (Scopus)

Abstract

Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.

Lingua originale	Inglese
pagine (da-a)	547-554
Numero di pagine	8
Rivista	Annals of Medicine
Volume	46
Numero di pubblicazione	7
DOI	https://doi.org/10.3109/07853890.2014.941919
Stato di pubblicazione	Pubblicato - 2014
Pubblicato esternamente	Sì

All Science Journal Classification (ASJC) codes

Medicina Generale

Keywords

Ankylosing spondylitis
anti-TNF
inflammatory bowel diseases
methotrexate
psoriasis
rheumatoid arthritis
tuberculosis

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.3109/07853890.2014.941919

Altri file e collegamenti

Cita questo

Lorenzetti, R., Zullo, A., Ridola, L., Diamanti, A., Laganà, B., Gatta, L., Migliore, A., Armuzzi, A., Hassan, C., & Bruzzese, V. (2014). Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials. Annals of Medicine, 46(7), 547-554. https://doi.org/10.3109/07853890.2014.941919

@article{59fc9e75ddb74085a1dcf21536cb0392,

title = "Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials",

abstract = "Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.",

keywords = "Ankylosing spondylitis, anti-TNF, inflammatory bowel diseases, methotrexate, psoriasis, rheumatoid arthritis, tuberculosis, Ankylosing spondylitis, anti-TNF, inflammatory bowel diseases, methotrexate, psoriasis, rheumatoid arthritis, tuberculosis",

author = "R Lorenzetti and A Zullo and L Ridola and Ap Diamanti and B Lagan{\`a} and L Gatta and A Migliore and Alessandro Armuzzi and C Hassan and V. Bruzzese",

year = "2014",

doi = "10.3109/07853890.2014.941919",

language = "English",

volume = "46",

pages = "547--554",

journal = "Annals of Medicine",

issn = "0785-3890",

publisher = "Taylor and Francis Ltd.",

number = "7",

}

Lorenzetti, R, Zullo, A, Ridola, L, Diamanti, A, Laganà, B, Gatta, L, Migliore, A, Armuzzi, A, Hassan, C & Bruzzese, V 2014, 'Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials', Annals of Medicine, vol. 46, n. 7, pagg. 547-554. https://doi.org/10.3109/07853890.2014.941919

TY - JOUR

T1 - Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

AU - Lorenzetti, R

AU - Zullo, A

AU - Ridola, L

AU - Diamanti, Ap

AU - Laganà, B

AU - Gatta, L

AU - Migliore, A

AU - Armuzzi, Alessandro

AU - Hassan, C

AU - Bruzzese, V.

PY - 2014

Y1 - 2014

N2 - Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.

AB - Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.

KW - Ankylosing spondylitis

KW - anti-TNF

KW - inflammatory bowel diseases

KW - methotrexate

KW - psoriasis

KW - rheumatoid arthritis

KW - tuberculosis

KW - Ankylosing spondylitis

KW - anti-TNF

KW - inflammatory bowel diseases

KW - methotrexate

KW - psoriasis

KW - rheumatoid arthritis

KW - tuberculosis

UR - https://publicatt.unicatt.it/handle/10807/64556

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84909996049&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84909996049&origin=inward

U2 - 10.3109/07853890.2014.941919

DO - 10.3109/07853890.2014.941919

M3 - Article

SN - 0785-3890

VL - 46

SP - 547

EP - 554

JO - Annals of Medicine

JF - Annals of Medicine

IS - 7

ER -

Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

Abstract

All Science Journal Classification (ASJC) codes

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo